Imperial College London

Dr Nik Ding

Faculty of MedicineDepartment of Surgery & Cancer

Honorary Clinical Lecturer







Northwick ParkNorthwick Park and St Marks Site






Research degree in "personalising medical therapy in Crohn's disease".

Interest in database research and review of clinical, endoscopic, radiologic and biochemical factors.

Further laboratory-based research in metabonomics at South Kensington.


  • Supervision of two research students: BSc and MRes.
  • Consultant Gastroenterologist
  • Head of IBD Clinical Trials Unit



Tassone D, Gilmore R, Lee T, et al., 2023, Letter: diagnostic delay in inflammatory bowel disease., Aliment Pharmacol Ther, Vol:57, Pages:1203-1204

Gilmore R, Tassone D, Ding NS, 2023, Letter: tofacitinib in the real world - do clinical trial data stand up?, Aliment Pharmacol Ther, Vol:57, Pages:745-746

Noor NM, Sousa P, Bettenworth D, et al., 2023, ECCO Topical Review on Biological Treatment Cycles in Crohn's Disease, Journal of Crohns & Colitis, ISSN:1873-9946

Ding NS, Tassone D, Al Bakir I, et al., 2022, Systematic review: the impact and importance of body composition in inflammatory bowel disease, Journal of Crohns & Colitis, ISSN:1873-9946

Tassone D, Singh S, Sheng Ding N, 2021, Editorial: impact of body mass index on clinical outcomes in patients with ulcerative colitis treated with tofacitinib, Alimentary Pharmacology & Therapeutics, Vol:54, ISSN:0269-2813, Pages:206-207

More Publications